This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The last time I spoke about Recursion Pharmaceuticals (RXRX), it was with a Seeking Alpha article entitled "Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data." With respect to this ...

RXRX is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of RXRX shares has decreased $0.20 since the market last closed. This is a 4.96% ...

On September 12, 2025, EPA released a proposal to permanently remove program obligations for 46 source categories of the GHGRP in accordance with President Trump's Executive Order 14192, "Unleashing ...

You’re invited to attend the 2026 National Chemistry Week Program-in-a-Box! Celebrate this year's theme "Chemistry Under Construction" during this interactive hybrid event featuring trivia, giveaways, ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Heidi Borst is a writer, editor and certified nutrition coach who loves health and wellness. Before joining Forbes Health as a Staff Writer, her work appeared in The New York Times, The Washington ...